Latest News and Press Releases

Autolus Therapeutics Presents Long-Term Follow Up from the FELIX Study Demonstrating Obe-Cel's Potential for Long-Term Remission in R/R B-ALL at the 2025 E

Autolus will participate in upcoming investor conferences.

Autolus will present in a fireside chat at the Needham Healthcare Conference on Wednesday, April 9, 2025.

Autolus announces recent updates and financial results for the full year ended December 31, 2024.

Autolus will report Q4 and FY 2024 financial results and operational updates on March 20, 2025.

Autolus will participate in two upcoming investor conferences: Jefferies Biotech on the Beach and Leerink Global Biopharma Conference.

Autolus announces business updates and an overview of 2025 milestones.

Autolus Therapeutics Presents Clinical Data Updates at the American Society of Hematology (ASH) Annual Meeting 2024

Autolus Therapeutics Reports Third Quarter 2024 Financial Results and Business Updates

Autolus Therapeutics Presents Clinical Data Update at the 2024 Lymphoma, Leukemia & Myeloma Congress